DrugCite
Search

VIOXX

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Vioxx Adverse Events Reported to the FDA Over Time

How are Vioxx adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Vioxx, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Vioxx is flagged as the suspect drug causing the adverse event.

Most Common Vioxx Adverse Events Reported to the FDA

What are the most common Vioxx adverse events reported to the FDA?

Myocardial Infarction
12189 (12.58%)
Cerebrovascular Accident
9667 (9.98%)
Cardiovascular Disorder
3189 (3.29%)
Thrombosis
3043 (3.14%)
Pulmonary Embolism
2463 (2.54%)
Chest Pain
2272 (2.35%)
Death
2246 (2.32%)
Hypertension
1920 (1.98%)
Angina Pectoris
1857 (1.92%)
Arrhythmia
1609 (1.66%)
Cardiac Disorder
1457 (1.5%)
Show More Show More
Injury
1349 (1.39%)
Coronary Artery Disease
1271 (1.31%)
Anxiety
1014 (1.05%)
Cardiac Failure
990 (1.02%)
Organ Failure
921 (.95%)
Cardiac Failure Congestive
911 (.94%)
Adverse Event
889 (.92%)
Pain
867 (.9%)
Acute Myocardial Infarction
844 (.87%)
Transient Ischaemic Attack
816 (.84%)
Renal Disorder
813 (.84%)
Ulcer
787 (.81%)
Deep Vein Thrombosis
762 (.79%)
Renal Failure
731 (.75%)
Depression
719 (.74%)
Dyspnoea
715 (.74%)
Renal Injury
575 (.59%)
Ischaemic Stroke
499 (.52%)
Embolism
498 (.51%)
Emotional Distress
497 (.51%)
Dizziness
470 (.49%)
Headache
436 (.45%)
Oedema Peripheral
373 (.39%)
Asthenia
361 (.37%)
Fatigue
352 (.36%)
Angiopathy
340 (.35%)
Blood Pressure Increased
340 (.35%)
Coronary Artery Occlusion
329 (.34%)
Cardiac Arrest
312 (.32%)
Nausea
288 (.3%)
Heart Injury
280 (.29%)
Blood Cholesterol Increased
277 (.29%)
Atrial Fibrillation
272 (.28%)
Hypoaesthesia
264 (.27%)
Pain In Extremity
261 (.27%)
Angina Unstable
255 (.26%)
Liver Disorder
254 (.26%)
Arteriosclerosis
250 (.26%)
Hyperlipidaemia
244 (.25%)
Anaemia
243 (.25%)
Fall
243 (.25%)
Palpitations
239 (.25%)
Anhedonia
237 (.24%)
Cerebral Infarction
235 (.24%)
Gastrointestinal Haemorrhage
230 (.24%)
Vomiting
230 (.24%)
Gastrooesophageal Reflux Disease
227 (.23%)
Back Pain
213 (.22%)
Coronary Artery Stenosis
208 (.21%)
Diarrhoea
199 (.21%)
Mitral Valve Incompetence
198 (.2%)
Pneumonia
198 (.2%)
Syncope
196 (.2%)
Loss Of Consciousness
189 (.2%)
Diabetes Mellitus
186 (.19%)
Arthropathy
181 (.19%)
Myocardial Ischaemia
179 (.18%)
Insomnia
178 (.18%)
Multi-organ Disorder
178 (.18%)
Arthralgia
176 (.18%)
Overdose
172 (.18%)
Cardiomegaly
169 (.17%)
Abdominal Pain Upper
165 (.17%)
Drug Ineffective
162 (.17%)
Chronic Obstructive Pulmonary Disea...
161 (.17%)
Cerebrovascular Disorder
156 (.16%)
Acute Coronary Syndrome
155 (.16%)
Arteriosclerosis Coronary Artery
155 (.16%)
Convulsion
153 (.16%)
Urinary Tract Infection
153 (.16%)
Dyspepsia
152 (.16%)
Tachycardia
151 (.16%)
Hypotension
150 (.15%)
Chest Discomfort
149 (.15%)
Renal Failure Acute
145 (.15%)
Arterial Occlusive Disease
144 (.15%)
Heart Rate Irregular
137 (.14%)
Abdominal Pain
136 (.14%)
Emotional Disorder
128 (.13%)
Feeling Abnormal
126 (.13%)
Osteoarthritis
126 (.13%)
Amnesia
125 (.13%)
Ventricular Hypertrophy
122 (.13%)
Heart Rate Increased
118 (.12%)
Asthma
115 (.12%)
Bradycardia
115 (.12%)
Hypercholesterolaemia
115 (.12%)
Vascular Injury
115 (.12%)
Gastric Ulcer
112 (.12%)
Tricuspid Valve Incompetence
111 (.11%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Vioxx, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Vioxx is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Vioxx

What are the most common Vioxx adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Vioxx, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Vioxx is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Vioxx According to Those Reporting Adverse Events

Why are people taking Vioxx, according to those reporting adverse events to the FDA?

Arthritis
14554
Arthralgia
5964
Osteoarthritis
5428
Back Pain
4527
Pain
4279
Rheumatoid Arthritis
2106
Show More Show More
Pain In Extremity
1182
Inflammation
706
Monarthritis
608
Pain Management
572
Neck Pain
570
Shoulder Pain
568
Ill-defined Disorder
535
Fibromyalgia
524
Drug Use For Unknown Indication
444
Myalgia
355
Spondylitis
324
Gout
285
Back Injury
267
Arthropathy
253
Localised Osteoarthritis
252
Intervertebral Disc Protrusion
252
Musculoskeletal Pain
240
Intervertebral Disc Degeneration
224
Tendonitis
219
Joint Injury
216
Bursitis
208
Spinal Osteoarthritis
201
Back Disorder
191
Carpal Tunnel Syndrome
188
Ankylosing Spondylitis
186
Polyarthritis
175
Bone Pain
168
Analgesic Effect
162
Headache
161
Rotator Cuff Syndrome
144
Neoplasm Prophylaxis
143
Osteoporosis
141
Post Procedural Pain
136
Spinal Column Stenosis
133
Psoriatic Arthropathy
129
Limb Injury
126
Sciatica
121
Muscle Spasms
110
Exostosis
89
Systemic Lupus Erythematosus
88
Knee Operation
84
Migraine
82
Surgery
80
Joint Swelling
75
Procedural Pain
73

Vioxx Case Reports

What Vioxx safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Vioxx. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Vioxx.